← Open Payments lookup

THU TRAN: Open Payments

NPI 1255767844 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,718 in 91 payments from 19 companies in 2025. Trend: 2023 $1,936 · 2024 $2,594 · 2025 $1,718

Food & beverage: $1,718
CompanyPaymentsAmount
Amgen Inc.19$275
AstraZeneca Pharmaceuticals LP11$208
ABBVIE INC.12$202
Janssen Biotech, Inc.8$184
PFIZER INC.5$110
Novartis Pharmaceuticals Corporation4$99
GlaxoSmithKline, LLC.3$84
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$83
ANI Pharmaceuticals, Inc.3$69
Sumitomo Pharma America, Inc.4$69

Products named: TREMFYA, RINVOQ, COSENTYX, TAVNEOS, OTEZLA, BENLYSTA, CAPLYTA, XELJANZ.

Industry payments across MS — which companies pay providers there.